Cleared Special

ADAS 3D (K210850) - FDA 510(k) Clearance

Class II Radiology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K210850 · Adas3D Medical S.L. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2021
Decision
14d
Days
Class 2
Risk

K210850 is an FDA 510(k) clearance for the ADAS 3D. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Adas3D Medical S.L. (Barcelona, ES). The FDA issued a Cleared decision on April 5, 2021 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Incremental AI imaging tool. Low regulatory complexity profile. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Adas3D Medical S.L. devices

Submission Details

510(k) Number K210850 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 22, 2021
Decision Date April 05, 2021
Days to Decision 14 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
93d faster than avg
Panel avg: 107d · This submission: 14d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 799
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K210850.
PtoleMedic System
K202521 · Lento Medical Innovation, Inc. · May 2021
SOTA Cloud Imaging
K210682 · Sota Precision Optics, Inc. Dba Sota Imaging · May 2021
DeepLook PRECISE
K202084 · Deeplook, Inc. · Apr 2021
Simpleware ScanIP Medical
K203195 · Synopsys (Northern Europe) , Ltd. · Apr 2021
SIS System (Version 5.1.0)
K210071 · Surgical Information Sciences, Inc. · Mar 2021
Quicktome
K203518 · Omniscient Neurotechnology Pty Ltd (O8t) · Mar 2021